Status:
COMPLETED
Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
HIV Infections
Eligibility:
All Genders
8-19 years
Brief Summary
Taking anti-HIV medication consistently and properly is a critical issue for patients with HIV. Drug regimens are complex; when regimens are not taken properly, HIV can become resistant to the drugs. ...
Detailed Description
Medication adherence is a critical issue for HIV infected children and adolescents because of drug resistance and the increased complexity of treatment regimens. Children and adolescents with HIV face...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- HIV-1 perinatal infection
- Already enrolled and in active follow-up in PACTG 219C
- Can communicate in English or Spanish
- On antiretroviral medication regimen at the time of enrollment, regardless of compliance with regimen, with no planned treatment interruptions
- Exclusion Criteria
- Acquired HIV via routes other than perinatal transmission or source of HIV infection is unknown
- HIV-2 infection
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
End Date :
October 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00073424
Start Date
January 1 2004
End Date
October 1 2006
Last Update
June 3 2013
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB, Dept. of Ped., Div. of Infectious Diseases
Birmingham, Alabama, United States, 35233
2
Phoenix Children's Hosp.
Phoenix, Arizona, United States, 85006
3
Long Beach Memorial Med. Ctr., Miller Children's Hosp.
Long Beach, California, United States, 90801
4
Usc La Nichd Crs
Los Angeles, California, United States, 90033